4.1 Article

Prognostic Role of Admission C-Reactive Protein Level as a Predictor of In-Hospital Mortality in Type-A Acute Aortic Dissection: A Meta-Analysis

Journal

VASCULAR AND ENDOVASCULAR SURGERY
Volume 53, Issue 7, Pages 547-557

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/1538574419858161

Keywords

C-reactive protein; acute aortic dissection; type-A; mortality; prognosis

Ask authors/readers for more resources

Background: Acute aortic dissection (AD) is a lethal vascular disease, accounting for over 90% cases of acute aortic syndrome. Despite advances in understanding associated risk factors, the long-term prognosis for AD patients is still poor. Several prognostic biomarkers have been used for AD as per the IRAD, such as older age (>70 years), onset of chest pain and hypotension, but they are not effective in all patients. Instead, C-reactive protein (CRP) is a consistent inflammatory marker. CRP levels are abnormally increased in AD. However, the prognostic value of serum CRP level in AD remains unclear. Objective: To perform a systematic review and meta-analysis (registration no CRD42017056205) to evaluate whether CRP is a biomarker associated with in-hospital mortality in type-A AD. Methods: PubMed, Web of Science, CNKI, SciELO, and EMBASE were searched for papers published from January 2000 to October 2017 for studies on the prognostic role of CRP at admission in type-A AD patients. Outcome data were extracted and pooled hazard ratios (HRs) were calculated. Results: 18 (N = 2875 patients) studies met the inclusion criteria. Elevated CRP level was associated with a significantly increased risk of in-hospital mortality in patients with type-A AD (HR = 1.15, 95% CI: 1.06-1.25, p = 0.001). The pooled sensitivity of CRP in type-A AD patients was 77% (95% CI 69%-84%, p < 0.001), and the specificity was 72% (95% CI 66%-78%, p < 0.001). Conclusion: Elevated CRP level is significantly associated with increased risks of in-hospital mortality in patients with type-A AD. CRP is a convenient prognostic factor in type-A AD patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Radiology, Nuclear Medicine & Medical Imaging

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients

Mohammed Fawzi Abosamak, Brandon M. Henry, Mahmoud Fawzi Aly, Carl. J. Lavie, Fabian Sanchis-Gomar

ACADEMIC RADIOLOGY (2021)

Article Medical Laboratory Technology

The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)

Brandon Michael Henry, Stefanie W. Benoit, Jens Vikse, Brandon A. Berger, Christina Pulvino, Jonathan Hoehn, James Rose, Maria Helena Santos de Oliveira, Giuseppe Lippi, Justin L. Benoit

Summary: This study found that IL-10 and IL-10/lymphocyte count levels were significantly higher in severe COVID-19 cases, as well as in those with severe AKI and new positive bacterial cultures. IL-10 and IL-10/lymphocyte count were independent predictors of COVID-19 severity.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Critical Care Medicine

Outcomes of Multiple Runs of Extracorporeal Membrane Oxygenation: An analysis of the Extracorporeal Life Support Registry

David Cooper, Ravi Thiagarajan, Brandon Michael Henry, Jonathan W. Byrnes, Andrew Misfeldt, Jason Frischer, Eileen King, Zhiqian Gao, Peter Rycus, Bradley S. Marino

Summary: This study found that the outcomes of multiple runs of ECMO remain poor. Survival decreases with each additional run. Patients requiring additional runs for pulmonary indications should be considered prime candidates. Renal complications on the first run significantly increase the risk of mortality on subsequent runs.

JOURNAL OF INTENSIVE CARE MEDICINE (2022)

Letter Pharmacology & Pharmacy

Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA

Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2022)

Article Hematology

Laboratory testing for ADAMTS13: Utility for TTP diagnosis/exclusion and beyond

Emmanuel J. Favaloro, Leonardo Pasalic, Brandon Henry, Giuseppe Lippi

Summary: The article introduces the role and detection methods of the metalloproteinase ADAMTS13 in clinical conditions such as thrombotic thrombocytopenic purpura, as well as discusses the limitations and potential utility of rapid ADAMTS13 testing methods.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Letter Peripheral Vascular Disease

Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19)

Brandon Michael Henry, Maria Helena Santos de Oliveira, Isaac Cheruiyot, Justin L. Benoit, David S. Cooper, Giuseppe Lippi, Timothy D. Le Cras, Stefanie W. Benoit

ANGIOGENESIS (2021)

Article Pathology

Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study

Brandon Michael Henry, Isaac Cheruiyot, Stefanie W. Benoit, Fabian Sanchis-Gomar, Giuseppe Lippi, Justin Benoit

Summary: Necrosis seems to be the main driver of hospitalization in COVID-19 patients, while apoptosis and necrosis appear to drive ICU admission. Elevated levels of CK-18 are independent predictors of severe disease, and could be useful for risk stratification of COVID-19 patients and assessment of therapeutic efficacy in early-phase clinical trials.

JOURNAL OF CLINICAL PATHOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Aspirin resistance in infants with shunt-dependent congenital heart disease

Wonshill Koh, Megan Rodts, Ashley Nebbia, Jaclyn Sawyer, Brandon Henry, David S. Cooper

Summary: Patients with cyanotic heart disease are at an increased risk of thrombosis. Aspirin has been the main prophylactic anticoagulation method, but there is prevalent aspirin resistance, especially in neonates. This study found that low birth weight is associated with a higher incidence of aspirin resistance, and inadequate initial dosing is the primary reason for resistance. While there was no significant difference in thrombotic events between resistance and non-resistance groups, the presence of both thrombotic events and aspirin resistance was associated with significantly higher in-hospital mortality.

CARDIOLOGY IN THE YOUNG (2022)

Letter Medical Laboratory Technology

Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients

Giuseppe Lippi, Brandon M. Henry, Emmanuel J. Favaloro

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Letter Medicine, General & Internal

Searching for a clinically validated definition of asymptomatic COVID-19 infection

Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar, Camilla Mattiuzzi

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Letter Infectious Diseases

Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?

Camilla Mattiuzzi, Brandon M. Henry, Giuseppe Lippi

JOURNAL OF INFECTION (2022)

Article Cardiac & Cardiovascular Systems

Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies

Brandon Michael Henry, Alexis L. Benscoter, Maria Helena Santos de Oliveira, Jens Vikse, Tanya Perry, David S. Cooper

Summary: Extracorporeal Membrane Oxygenation (ECMO) has a reasonable survival rate in children with primary immunodeficiencies (PID) who require respiratory support. The type of immunodeficiency and the decade of support do not affect survival rates. The presence of a pre-ECMO infection or infection during the ECMO run does not impact survival rates. Cardiac, pulmonary, and neurological complications are independently associated with increased mortality.

PERFUSION-UK (2023)

Article Hematology

COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?

Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi

Summary: Antiphospholipid antibodies (aPL) reflect a potential prothrombotic risk in several autoimmune conditions, especially antiphospholipid syndrome (APS). While various aPL have been found in COVID-19 patients, most identified solid-phase aPL have low titers and cannot be well-linked to the thrombotic aspects of COVID-19. High-titer or multiple aPL positivity is rare in COVID-19 presentations, suggesting a limited presence of APS in COVID-19 patients.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2022)

Article Hematology

Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature

Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi

Summary: The presence of lupus anticoagulant (LA) in COVID-19 patients is potentially related to the severity of infection, but the relationship between LA and COVID-19-associated coagulopathy needs to be further investigated. Many confounders, such as anticoagulant therapy and elevated CRP levels, may affect the identification of LA. Larger and better studies are needed to clarify the role of LA in COVID-19 pathology.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2022)

Article Medicine, General & Internal

Is body temperature mass screening a reliable and safe option for preventing COVID-19 spread?

Giuseppe Lippi, Riccardo Nocini, Camilla Mattiuzzi, Brandon Michael Henry

Summary: The current strategy of mass screening body temperature has several drawbacks, such as a high rate of asymptomatic infections, difficulty in defining normal body temperature, and device inaccuracy.

DIAGNOSIS (2022)

No Data Available